Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
126 Cards in this Set
- Front
- Back
|
Levothyroxine (Synthroid, Levoxyl, Levothiroid, Unithroid)
|
T4 Thyroid Agent
|
|
|
Liothyronine (Cytomel)
|
T3 Thyroid Agent
|
|
|
Thyrolar
|
T3 + T4 Thyroid Agent
|
|
|
Propylthiouracil (PTU)
|
Antithyroid Agent Thioperoxidase Inhibitor
|
|
|
Methimazole
|
Antithyroid Agent Thioperoxidase Inhibitor
|
|
|
Thiocyanate
|
Antithyroid Agent Ionic Inhibitor
|
|
|
Perchlorate
|
Antithyroid Agent Ionic Inhibitor
|
|
|
Lugol's Solution
|
Antithyroid Agent (Protection against radioactive thyroid)
|
|
|
SSKI
|
Antithyroid Agent (Protection against radioactive thyroid)
|
|
|
I 131
|
Thyroid Ablating Agent
|
|
|
Prochlorperazine (Compazine)
|
Anti-emetic Agent D2 receptor antagonist
|
|
|
Trimethobenzamide (Tigan)
|
Anti-emetic Agent D2 receptor antagonist
|
|
|
Promethazine (Phenergan)
|
Anti-emetic Agent D2 receptor antagonist
|
|
|
Ondansetron (Zofran)
|
Anti-emetic Agent 5-HT3 receptor antagonist
|
|
|
Granisetron (Kytril)
|
Anti-emetic Agent 5-HT3 receptor antagonist
|
|
|
Dolasetron (Anzemet)
|
Anti-emetic Agent 5-HT3 receptor antagonist
|
|
|
Metoclopramide (Reglan)
|
Anti-emetic Agent 5-HT3 receptor antagonist + D2 receptor antagonist
|
|
|
Cisapride (Animals only)
|
Anti-emetic Agent 5-HT3 receptor antagonist (Blocks delayed rectifier current)
|
|
|
Aprepitant/fosaprepitant (Emend)
|
Anti-emetic Agent NK-1 receptor antagonist
|
|
|
Dronabinol (Marinol)
|
Anti-emetic Agent CB-1 receptor agonist
|
|
|
Nabilone (Cesamet)
|
Anti-emetic Agent CB-1 receptor agonist
|
|
|
Alosetron (Lotronex)
|
IBS Agent (diarrhea) 5-HT3 antagonist
|
|
|
Lubiprostone (Amitiza)
|
IBS Agent (Constipation) Cl- ion channel opener
|
|
|
Misoprostol (Cytotec)
|
Anti-Ulcer Agent PGE2 receptor agonist
|
|
|
Sucralfate (Carafate)
|
Anti-Ulcer Agent Polymer protective agent
|
|
|
Cimetidine (Tagamet)
|
Anti-Ulcer Agent H2 receptor antagonist
|
|
|
Ranitidine (Zantac)
|
Anti-Ulcer Agent H2 receptor antagonist
|
|
|
Nizatidine (Axid)
|
Anti-Ulcer Agent H2 receptor antagonist
|
|
|
Famotidine (Pepcid)
|
Anti-Ulcer Agent H2 receptor antagonist
|
|
|
Omeprazole (Prilosec, Zegerid)
|
Anti-Ulcer Agent Proton Pump Inhibitor
|
|
|
Esomeprazole (Nexium)
|
Anti-Ulcer Agent Proton Pump Inhibitor
|
|
|
Lansoprazole (Prevacid)
|
Anti-Ulcer Agent Proton Pump Inhibitor
|
|
|
Dexlanzoprazole (Kapidex/Dexilant)
|
Anti-Ulcer Agent Proton Pump Inhibitor
|
|
|
Rabeprazole (Aciphex)
|
Anti-Ulcer Agent Proton Pump Inhibitor
|
|
|
Pantoprazole (Protonix)
|
Anti-Ulcer Agent Proton Pump Inhibitor
|
|
|
Omalizumab (Xolair)
|
Anti-hypersensitivity agent Anti-IgE drug
|
|
|
Cromolyn
|
Anti-hypersensitivity agent Mast Cell stabilizer
|
|
|
Nedocromil
|
Anti-hypersensitivity agent Mast Cell stabilizer
|
|
|
Diphenhydramine (Benadryl)
|
1st Generation H-1 receptor antagonist
|
|
|
Clemastine (Tavist)
|
1st Generation H-1 receptor antagonist
|
|
|
Dimenhydrinate (Dramamine)
|
1st Generation H-1 receptor antagonist
|
|
|
Chlorpheniramine (Chlor-Trimeton)
|
1st Generation H-1 receptor antagonist
|
|
|
Brompheniramine
|
1st Generation H-1 receptor antagonist
|
|
|
Hydroxyzine (Atarax/Vistaril)
|
1st Generation H-1 receptor antagonist
|
|
|
Cyclizine
|
1st Generation H-1 receptor antagonist
|
|
|
Meclizine (Antivert)
|
1st Generation H-1 receptor antagonist
|
|
|
Loratidine (Claritin)
|
2nd Generation H-1 receptor antagonist
|
|
|
Desloratidine (Clarinex)
|
2nd Generation H-1 receptor antagonist
|
|
|
Cetirizine (Zyrtec)
|
2nd Generation H-1 receptor antagonist
|
|
|
Azelastine (Astelin)
|
2nd Generation H-1 receptor antagonist
|
|
|
Fexofenadine (Allegra)
|
2nd Generation H-1 receptor antagonist
|
|
|
Cyproheptadine (Periactin)
|
Anti-histamine effects
|
|
|
Doxepin
|
TCA (Anti-histamine and anti-muscarinic effects)
|
|
|
Mechlorethamine (Mustargen)
|
Anti-neoplastic agents Alkylating Agent (Nitrogen Mustard)
|
|
|
Chlorambucil (Leukeran)
|
Anti-neoplastic agents Alkylating Agent (Nitrogen Mustard)
|
|
|
Melphalan (Alkeran)
|
Anti-neoplastic agents Alkylating Agent (Nitrogen Mustard)
|
|
|
Cyclophosphamide (Cytoxan)
|
Anti-neoplastic agents Alkylating Agent (Nitrogen Mustard)
|
|
|
Ifosfamide (Ifex)
|
Anti-neoplastic agents Alkylating Agent (Nitrogen Mustard)
|
|
|
Carmustine (BCNU)
|
Anti-neoplastic agents Alkylating Agent (Nitrosurea)
|
|
|
Lomustine (CCNU)
|
Anti-neoplastic agents Alkylating Agent (Nitrosurea)
|
|
|
Dacarbazine (DTIC)
|
Anti-neoplastic agents Alkylating Agent (Triazene)
|
|
|
Procarbazine
|
Anti-neoplastic agents Alkylating Agent (Triazene)
|
|
|
Temozolomide
|
Anti-neoplastic agents Alkylating Agent (Triazene)
|
|
|
Cisplatin
|
Anti-neoplastic agents Alkylating Agent (Platinum Coordination Complexes)
|
|
|
Carboplatin
|
Anti-neoplastic agents Alkylating Agent (Platinum Coordination Complexes)
|
|
|
Oxaliplatin
|
Anti-neoplastic agents Alkylating Agent (Platinum Coordination Complexes)
|
|
|
Methotrexate
|
Anti-Metabolite DHFR and TS Inhibitor
|
|
|
Pemetrexed
|
Anti-Metabolite DHFR, TS, GARFT Inhibitor
|
|
|
6-Mercaptopurine (6-MP)
|
Anti-Metabolite Purine Analog (Inhibitor of Purine Metabolism)
|
|
|
Thioguanine (TG)
|
Anti-Metabolite Purine Analog (Inhibitor of Purine Metabolism)
|
|
|
Fludarabine
|
Anti-Metabolite Purine Analog (Incorporation in DNA - chain terminator)
|
|
|
Cladribine
|
Anti-Metabolite Purine Analog (Incorporation into DNA - chain terminator)
|
|
|
5-Fluorouracil (5-FU)
|
Anti-Metabolite Pyrimidine Analog (Inhibitor of Thymidylate Synthase)
|
|
|
Capecitabine
|
Anti-Metabolite Pyrimidine Analog (Inhibitor of Thymidylate Synthase)
|
|
|
Cytarabine (Ara-C)
|
Anti-Metabolite Pyrimidine Analog (Incorporation into DNA - chain terminator)
|
|
|
Gemcitabine
|
Anti-Metabolite Pyrimidine Analog (Incorporation into DNA - chain terminator)
|
|
|
Azacytidine
|
Anti-Metabolite Pyrimidine Analog (Inhibitor of DNA methylations)
|
|
|
Decitabine
|
Anti-Metabolite Pyrimidine Analog (Inhibitor of DNA methylations)
|
|
|
Hydroxyurea
|
Ribonucleotide Reductase Inhibitor
|
|
|
Vincristine
|
Anti-Mitotic Agent Vinca Alkaloid
|
|
|
Vinblastine
|
Anti-Mitotic Agent Vinca Alkaloid
|
|
|
Vinorelbine
|
Anti-Mitotic Agent Vinca Alkaloid
|
|
|
Paclitaxel
|
Anti-Mitotic Agent Taxane
|
|
|
Docetaxel
|
Anti-Mitotic Agent Taxane
|
|
|
Nab-Paclitaxel (Abraxane)
|
Anti-Mitotic Agent Taxane
|
|
|
Cabazitaxel
|
Anti-Mitotic Agent Taxane
|
|
|
Ixabepilone
|
Anti-Mitotic Agent Epothilone
|
|
|
Irinotecan (CPT-11)
|
Topoisomerase I Inhibitor Camptotecans
|
|
|
Topotecan
|
Topoisomerase I Inhibitor Camptotecans
|
|
|
Etoposide (VP-16)
|
Topoisomerase II Inhibitor Epipodophyllotoxin
|
|
|
Teniposide (VN-26)
|
Topoisomerase II Inhibitor Epipodophyllotoxin
|
|
|
Daunorubicin
|
Topoisomerase II Inhibitor Anthracyclines
|
|
|
Doxorubicin
|
Topoisomerase II Inhibitor Anthracyclines
|
|
|
Epirubicin
|
Topoisomerase II Inhibitor Anthracyclines
|
|
|
Idarubicin
|
Topoisomerase II Inhibitor Anthracyclines
|
|
|
Mitoxantrone
|
Topoisomerase II Inhibitor Anthracyclines
|
|
|
Aminoglutethimide
|
Aromatase Inhibitor (irreversible) 1st Generation
|
|
|
Anastrazole
|
Aromatase Inhibitor (Reversible) 3rd generation
|
|
|
Letrozole
|
Aromatase Inhibitor (Reversible) 3rd generation
|
|
|
Exemestane
|
Aromatase Inhibitor (Reversible) 3rd generation
|
|
|
Bortezomib
|
Proteosome Inhibitor (Inhibits 26-S Proteosome, increase IKB)
|
|
|
Thalidomide
|
TNF alpha Inhibitor, Anti-angiogenesis effect
|
|
|
Lenalidomide
|
TNF alpha Inhibitor, Anti-angiogenesis effect
|
|
|
L-Asparginase
|
L-Aspargine hydrolyzing agent
|
|
|
Ipilimumab
|
Monoclonal Antibody against Cytotoxic T-Lymphocyte Associated Antigen-4 (CTLA-4)
|
|
|
Sipuleucel-T
|
Metastatic Prostate Cancer Agent (Autologeus Treatment)
|
|
|
Rituximab
|
Monoclonal Antibody against CD20 on mature B cells - Non-Hodgkin's Lymphoma agent
|
|
|
I131 Tositubmomab
|
Monoclonal Antibody against CD20 on mature B cells - Non-Hodgkin's Lymphoma agent
|
|
|
Y90 Ibritumomab
|
Monoclonal Antibody against CD20 on mature B cells - Non-Hodgkin's Lymphoma agent (NHL)
|
|
|
Alemtuzumab
|
Monoclonal Antibody against CD52 on T-Lymphocytes - Chronic Lymphocytic Leukemia (CLL)
|
|
|
Erlotinib
|
EGFR Tyrosine Kinase Inhibitor - NSCLC agent
|
|
|
Geftinib
|
EGFR Tyrosine Kinase Inhibitor - NSCLC agent (No longer available in US)
|
|
|
Bevacizumab
|
Monoclonal Antibody - VEGF receptor - Renal cell carcinoma, breast cancer, colorectal cancer, NSCLC agent
|
|
|
Lapatinib
|
HER2 Tyrosine Kinase Inhibitor - HER2+ breast cancer
|
|
|
Sorafenib
|
VEGF Tyrosine Kinase Inhibitor - Renal cell carcinoma
|
|
|
Sunitinib
|
VEGF Tyrosine Kinase Inhibitor - Renal cell carcinoma
|
|
|
Pazopanib
|
VEGF Tyrosine Kinase Inhibitor - Renal cell carcinoma
|
|
|
Imatinib (Gleevac)
|
1st Generation BCR-ABL Tyrosine Kinase Inhibitor
|
|
|
Dasatinib
|
2nd Generation BCR-ABL Tyrosine Kinase Inhibitor
|
|
|
Panitumumab
|
Monoclonal Antibody against EGFR
|
|
|
Nilotinib
|
2nd Generation BCR-ABL Tyrosine Kinase Inhibitor
|
|
|
Cetuximab
|
Monoclonal Antibody against EGFR receptor
|
|
|
Panitumumab
|
Monoclonal Antibody against EGFR receptor
|
|
|
Trastuzumab
|
Monoclonal Antibody against HER2 receptor
|
|
|
Everolimus
|
mTOR Inhibitor
|
|
|
Temsiorlimus
|
mTOR Inhibitor - Advanced Renal cell carcinoma agent
|
